{
    "organizations": [],
    "uuid": "7eae18f9d82ccd5e4e058b365ea7f347e4ec25ea",
    "author": "",
    "url": "https://www.reuters.com/article/brief-newlink-genetics-reviews-clinical/brief-newlink-genetics-reviews-clinical-programs-idUSFWN1RJ0GM",
    "ord_in_thread": 0,
    "title": "BRIEF-Newlink Genetics Reviews Clinical Programs",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 6, 2018 / 7:05 PM / in 12 minutes BRIEF-Newlink Genetics Reviews Clinical Programs Reuters Staff \nApril 6 (Reuters) - Newlink Genetics: * NEWLINK GENETICS ANNOUNCES REVIEW OF CLINICAL PROGRAMS \n* IN LIGHT OF INCYTEâ€™S ANNOUNCEMENT REGARDING ECHO-301 TRIAL, CO UNDERTAKING REVIEW OF CLINICAL PROGRAMS Source text for Eikon: Further company coverage:",
    "published": "2018-04-06T22:03:00.000+03:00",
    "crawled": "2018-04-06T22:29:17.053+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "minute",
        "genetics",
        "review",
        "clinical",
        "program",
        "reuters",
        "staff",
        "april",
        "reuters",
        "newlink",
        "genetics",
        "newlink",
        "genetics",
        "announces",
        "review",
        "clinical",
        "program",
        "light",
        "incyte",
        "announcement",
        "regarding",
        "trial",
        "co",
        "undertaking",
        "review",
        "clinical",
        "program",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}